Anbiping

China
Jiaoweixiang, Guangdong, China

Company profile

Anbiping company profile

Anbiping is a number of reagents and supporting devices have indeed been independently created by Anbiping, which focuses on tumour screening and correct diagnosis. Pathology is the main application department. It has been established that product lines for liquid-based cytology, polymerase chain reaction, immunohistochemistry, and fluorescence in situ hybridization can be used to screen for and diagnose tumors based on everything from cell morphology to protein expression.

Business identity

Contact email
[email protected]
Phone number
+86-020-32299997
Operating status
Active
Company type
For Profit
Employee range
501-1,000 employees
Founded
2005-07-06

Headquarters

Country code
CN
Continent
Asia

Capital profile

Funding and company signals

Funding stage
M And A
Funding rounds
4
Total equity funding
$9.8M
Last funding
Series C / $4.4M / 2017-06-21
Last equity funding
Series C / $4.4M
Investors
11
Lead investors
1
Founders
1
Exited on
2020-08-20

Founders and investors

Founders

Xiangting Cai

Lead investors

Qushui Aiwei

Investors

CDF-CapitalJinshi InvestmentShenZhen GTJA Investment GroupSinopharm CapitalXinguodu